Complete Genomics Announces UK Epilepsy Society’s Acquisition of Its Revolocity™ Supersequencer
MOUNTAIN VIEW, Calif. – October 6, 2015 – Complete Genomics, Inc., a leader in whole human genome sequencing, announced today that leading UK charity Epilepsy Society has become the third customer of the company’s newly introduced Revolocity system, a supersequencer for large-scale, high-quality whole genome and whole exome sequencing.
“Genome sequencing
Read More